Steven Cohen's BCYC Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 130,422 shares of Bicycle Therapeutics plc (BCYC) worth $605,158, representing 0.00% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in BCYC, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 3.66 M shares. Largest reduction occurred in Q2 2025, reducing 1.92 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Bicycle Therapeutics plc (BCYC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bicycle Therapeutics plc (BCYC) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +53,643 | Add 69.87% | 130,422 | $4.64 |
| Q4 2025 | -354,121 | Reduce 82.18% | 76,779 | $7.08 |
| Q3 2025 | -1.34 M | Reduce 75.69% | 430,900 | $7.74 |
| Q2 2025 | -1.92 M | Reduce 51.99% | 1.77 M | $6.95 |
| Q1 2025 | -862,831 | Reduce 18.94% | 3.69 M | $8.49 |
| Q4 2024 | +3.66 M | Add 406.21% | 4.55 M | $14.00 |
| Q3 2024 | +841,299 | Add 1438.12% | 899,799 | $22.63 |
| Q2 2024 | -284,094 | Reduce 82.92% | 58,500 | $20.24 |
| Q1 2024 | +116,699 | Add 51.66% | 342,594 | $24.90 |
| Q4 2023 | -1.07 M | Reduce 82.62% | 225,895 | $18.08 |
| Q3 2023 | +821,500 | Add 171.86% | 1.3 M | $20.09 |
| Q2 2023 | -324,400 | Reduce 40.43% | 478,000 | $25.52 |
| Q1 2023 | -205,578 | Reduce 20.40% | 802,400 | $21.27 |
| Q4 2022 | -247,440 | Reduce 19.71% | 1.01 M | $29.60 |
| Q3 2022 | -189,582 | Reduce 13.12% | 1.26 M | $23.26 |
| Q2 2022 | -174,802 | Reduce 10.79% | 1.44 M | $16.78 |
| Q1 2022 | +46,979 | Add 2.99% | 1.62 M | $43.88 |
| Q4 2021 | -42,269 | Reduce 2.62% | 1.57 M | $60.87 |
| Q3 2021 | -190,843 | Reduce 10.57% | 1.62 M | $41.59 |
| Q2 2021 | +228,442 | Add 14.48% | 1.81 M | $30.36 |
| Q1 2021 | +139,917 | Add 9.73% | 1.58 M | $29.87 |
| Q4 2020 | +74,425 | Add 5.46% | 1.44 M | $17.95 |
| Q3 2020 | +962,652 | Add 240.36% | 1.36 M | $19.05 |
| Q1 2020 | +18,000 | Add 4.71% | 400,499 | $13.65 |
| Q4 2019 | +382,499 | New Buy | 382,499 | $9.43 |
Steven Cohen's Bicycle Therapeutics plc Investment FAQs
Steven Cohen first purchased Bicycle Therapeutics plc (BCYC) in Q4 2019, acquiring 382,499 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Bicycle Therapeutics plc (BCYC) for 26 quarters since Q4 2019.
Steven Cohen's largest addition to Bicycle Therapeutics plc (BCYC) was in Q4 2024, adding 4,554,900 shares worth $63.77 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 130,422 shares of Bicycle Therapeutics plc (BCYC), valued at approximately $605,158.
As of the Q1 2026 filing, Bicycle Therapeutics plc (BCYC) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Bicycle Therapeutics plc (BCYC) was 4,554,900 shares, as reported at the end of Q4 2024.